Literature DB >> 7957367

Dependence of the utilization of a phenylalanine-free amino acid mixture on different amounts of single dose ingested. A case report.

M E Herrmann1, H G Brösicke, M Keller, E Mönch, H Helge.   

Abstract

For patients with phenylketonuria the daily ingested phenylalanine-free amino acid mixture is the most important source of nitrogen. It is recommended to ingest one third of the total amount combined with main meals. Some patients, especially the older ones, do not follow this recommendation; they ingest the entire daily amount of amino acid mixture in one portion. This intake mode leads to an increased oxidative utilization of the amino acids. To set up an example for this metabolic phenomenon, a 13C-leucine breath test was performed in one female phenylketonuric patient. She ingested a third of her daily amount of the amino acid mixture combined with an oral tracer of 3 mg 13C-leucine/kg body weight at breakfast. The breath test was carried out by a standardized time schedule over 5 h. Three days later the breath test was repeated when she ingested the total amount of amino acid mixture in only one portion at breakfast. Total daily caloric intake and food composition were not changed. On both days a 24 h urine was collected to determine total nitrogen loss. The 13C-content of expired air was analysed by gas isotope ratio mass spectrometry, the total nitrogen content was determined using a combustion unit. The 13C-elimination rate as a percentage of the applied 13C-tracer was 9.5% on the first test day as compared to 19.6% on the 2nd day. The corresponding total nitrogen excretion was increased (4.3-6.9 g/24 h).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957367     DOI: 10.1007/BF01957005

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  6 in total

1.  Some regulatory mechanisms in the synthesis of urea in the mammalian liver.

Authors:  H A Krebs; R Hems; P Lund
Journal:  Adv Enzyme Regul       Date:  1973

Review 2.  Effects of ingestion of disproportionate amounts of amino acids.

Authors:  A E Harper; N J Benevenga; R M Wohlhueter
Journal:  Physiol Rev       Date:  1970-07       Impact factor: 37.312

3.  Modulation of leucine oxidation and turnover by graded amounts of carbohydrate intake in obese subjects.

Authors:  S A Adibi; R T Stanko; E L Morse
Journal:  Metabolism       Date:  1982-06       Impact factor: 8.694

4.  Effect of frequency of feeding of diets containing free or protein-bound lysine on the oxidation of [14C]lysine or [14C]phenylalanine by growing pigs.

Authors:  E S Batterham; H S Bayley
Journal:  Br J Nutr       Date:  1989-11       Impact factor: 3.718

5.  A theoretical basis for increasing current estimates of the amino acid requirements in adult man, with experimental support.

Authors:  V R Young; D M Bier; P L Pellett
Journal:  Am J Clin Nutr       Date:  1989-07       Impact factor: 7.045

6.  Urea synthesis after oral protein ingestion in man.

Authors:  R J Rafoth; G R Onstad
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

  6 in total
  10 in total

Review 1.  Nutrition therapy of organic acidaemias with amino acid-based formulas: emphasis on methylmalonic and propionic acidaemia.

Authors:  Steven Yannicelli
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

2.  The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria.

Authors:  M Hoeksma; M Van Rijn; P H Verkerk; A M Bosch; M F Mulder; J B C de Klerk; T J de Koning; E Rubio-Gozalbo; M de Vries; P J J Sauer; F J van Spronsen
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Acceptability of a new modular protein substitute for the dietary treatment of phenylketonuria.

Authors:  F J Rohr; A W Munier; H L Levy
Journal:  J Inherit Metab Dis       Date:  2001-11       Impact factor: 4.982

4.  Utilisation of amino acid mixtures in adolescents with phenylketonuria.

Authors:  E Mönch; M E Herrmann; H Brösicke; A Schöffer; M Keller
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

5.  Comparison of the protein quality of dietetically treated phenylketonuria patients with the recommendations of the WHO Expert Consultation.

Authors:  G Krauch; E Müller; A Anninos; H J Bremer
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

6.  Recommendations for protein and energy intakes by patients with phenylketonuria.

Authors:  P B Acosta
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 7.  Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature.

Authors:  M Huemer; C Huemer; D Möslinger; D Huter; S Stöckler-Ipsiroglu
Journal:  J Inherit Metab Dis       Date:  2007-07-11       Impact factor: 4.982

8.  Long-Term Growth in Phenylketonuria: A Systematic Review and Meta-Analysis.

Authors:  Fatma Ilgaz; Alex Pinto; Hülya Gökmen-Özel; Julio César Rocha; Esther van Dam; Kirsten Ahring; Amaya Bélanger-Quintana; Katharina Dokoupil; Erdem Karabulut; Anita MacDonald
Journal:  Nutrients       Date:  2019-09-03       Impact factor: 5.717

9.  Growth and Body Composition in PKU Children-A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes.

Authors:  Anne Daly; Wolfgang Högler; Nicola Crabtree; Nick Shaw; Sharon Evans; Alex Pinto; Richard Jackson; Boyd J Strauss; Gisela Wilcox; Júlio C Rocha; Catherine Ashmore; Anita MacDonald
Journal:  Nutrients       Date:  2021-04-16       Impact factor: 5.717

Review 10.  Glycomacropeptide in PKU-Does It Live Up to Its Potential?

Authors:  Anne Daly; Alex Pinto; Sharon Evans; Anita MacDonald
Journal:  Nutrients       Date:  2022-02-14       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.